Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach

Simple integer-based risk scores using available data could be used for predicting Aβ and tau positivity in individuals with MCI. Models have the potential to improve clinical trials through improved screening of individuals.

Authors

Institutions

Publication Details

Journal
The Journals of Gerontology Series B
Published
2025-05-02
DOI
https://doi.org/10.1093/geronb/gbaf085
Citations
1
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach

Ali Ezzati, Ilya M. Nasrallah, Danielle Harvey, Ellen Grober et al.
1 citations
The Journals of Gerontology Series B
Dementia and Cognitive Impairment Research
1.47
article

Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach

Ali Ezzati, Ilya M. Nasrallah, Danielle Harvey, Ellen Grober, Christos A. Davatzikos, Bhargav Teja Nallapu, Kellen K. Petersen, Richard Lipton
article en
1 citations

Abstract

Simple integer-based risk scores using available data could be used for predicting Aβ and tau positivity in individuals with MCI. Models have the potential to improve clinical trials through improved screening of individuals.

The Journals of Gerontology Series BVol. 80(7)
Albert Einstein College of Medicine (US), University of California, Irvine (US), Washington University in St. Louis (US), Laboratoire d’Imagerie Biomédicale (FR), University of Pennsylvania (US), University of California, Davis (US)
Foundation for the National Institutes of Health, Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Roche, Biogen, AbbVie, Cure Alzheimer's Fund, BioClinica, Novartis Pharmaceuticals Corporation, Takeda Pharmaceutical Company, Northern California Institute for Research and Education, Servier, Fujikura Foundation, IXICO, National Institutes of Health, Genentech, GE Healthcare, Canadian Institutes of Health Research, Eisai Incorporated, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, DoD Alzheimer's Disease Neuroimaging Initiative
Openalex Percentile: Top 20%
Dementia and Cognitive Impairment Research
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.